OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Immunopathology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Learning cell identity in immunology, neuroscience, and cancer	280
Micro-to multi-chimerism: the multiple facets of a singular phenomenon	91
Vascular galectins in tumor angiogenesis and cancer immunity	85
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors	75
The microbiome’s hidden influence: preclinical insights into inflammatory responses in necrotizing enterocolitis	68
Regulatory T lymphocytes as a therapy for ischemic stroke	62
Role of polyamines in intestinal mucosal barrier function	59
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16	56
Immune checkpoint for pregnancy	55
Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	55
The role of vaccines in the COVID-19 pandemic: what have we learned?	53
Regenerating the uterus: translational advances in endometrial bioengineering and immunotherapeutics	53
Thromboinflammatory challenges in stroke pathophysiology	52
Publisher Correction: Epithelial recognition and elimination against aberrant cells	51
Towards multiomic analysis of oral mucosal pathologies	51
Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries	49
The duality of microchimerism and cancer in parous women: a review and evolutionary perspective	46
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation	45
The role of microglia in early neurodevelopment and the effects of maternal immune activation	43
Immunization of preterm infants: current evidence and future strategies to individualized approaches	43
Single-cell RNA-seq methods to interrogate virus-host interactions	39
CAF-immune cell crosstalk and its impact in immunotherapy	39
Tolerance and autoimmunity in the liver	39
Dyslipidemia and female reproductive failures: perspectives on lipid metabolism and endometrial immune dysregulation	38
Correction to: MAIT cells in liver inflammation and fibrosis	35

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy	35
Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection	34
Unveiling the immunopathology of stroke: a comprehensive view on brain-immune interaction	33
Revisiting transplant immunology through the lens of single-cell technologies	33
Beyond defence: Immune architects of ovarian health and disease	29
Local anesthetics and immunotherapy: a novel combination to fight cancer	29
CAR T-cell behavior and function revealed by real-time imaging	29
Arginine metabolism in myeloid cells in health and disease	26
Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women	26
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment	25
Immune compartments at the brain’s borders in health and neurovascular diseases	24
Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition	24
How genetic risk contributes to autoimmune liver disease	23
Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers	23
Role of alarmins in poststroke inflammation and neuronal repair	22
Role of glia and extracellular matrix in controlling neuroplasticity in the central nervous system	21
Gut microbiota-derived metabolites tune host homeostasis fate	20
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy	20
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology	19
Proteomics to study cancer immunity and improve treatment	18
Maternal and placental galectins: key players in the feto-maternal symbiotic tango	18
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells	17
Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers	16
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke	16
Intracellular galectin interactions in health and disease	15
The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells	15
Tumor microenvironment antigens	15
The role of circulating cell-free DNA as an inflammatory mediator after stroke	15
Cell therapies for viral diseases: a new frontier	14
Physiological and immunological barriers in the lung	14
The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation	14
IgE and non-IgE-mediated pathways in anaphylaxis	14
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	14
Heterogeneity of tissue-resident immunity across organs and in health and disease	13
Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism	13